explore -WSS

explore

author：fashion 2025-08-29 19:58:35 - browse：1912

Traffic on the Longfellow Bridge and the Kendall Square skyline are seen. -- health coverage from STAT — Michael Dwyer/AP

Around this time three years ago, while most of us navigated pandemic life, real estate developers across Greater Boston looked to life-science laboratories, and saw dollar signs.

The white-collar office workers who’d long filled downtown towers were largely staying home (unless they worked in commercial real estate). The future of cities had rarely been murkier.

But many biotech companies, like Cambridge’s Moderna, were busier than ever, and growing fast. Life-science companies, and the lab buildings that house them, looked like a sure bet for investors. Money poured in to drug companies by the billions — from venture capitalists, the stock market, the National Institutes of Health. And big real estate investors followed, launching a wave of speculative lab development all over Greater Boston.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Readout LOUD podcast: How biotech is using artificial intelligence

WSS

Grad students accuse University of California of wage theft

What we’ve learned from the Aduhelm mess

How the messy conversation about Dolly changed bioethics

Senate bill would ban some hospital facility fees

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Assistant physicians can help address the primary care shortage

explore

explore

focus

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

How the messy conversation about Dolly changed bioethics

Anesthesiologist group: stop taking Ozempic before surgery

How digital tools helped lower hypertension in marginalized patients

What does generative AI mean for health care? We asked experts

'A game

After affirmative action ruling, medical educators look to 'holistic review'

Senate bill would ban some hospital facility fees

Duchenne breakthrough therapy leaves behind pioneering families

Patients, doctors press FTC to beef up hospital merger scrutiny

hotspot

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

Medicare to pay more for cardiac rehab in hospital outpatient clinics

'Revelatory' study finds a smoking impact that remains after quitting

A disappointing year of Humira biosimilars

The Readout: Gilead, Bernie Sanders, and other pharma news

David Liu startup to focus on CRISPR delivery

Wikipedia

Wikipedia

hotspot

leisure time